Niitsu N - Search Results

1

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study. The Adult Lymphoma Treatment Study Group (ALTSG).

Niitsu N, Okamoto M, Kuraishi Y, Nakamura S, Kodama F, Hirano M. Niitsu N, et al. Eur J Haematol. 2000 Sep;65(3):188-94. doi: 10.1034/j.1600-0609.2000.00250.x. Eur J Haematol. 2000. PMID: 11007055 Clinical Trial.

2

Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.

Niitsu N, Okamato M, Nakamine H, Yoshino T, Tamaru J, Nakamura S, Higashihara M, Hirano M. Niitsu N, et al. Eur J Haematol. 2002 Feb;68(2):91-100. doi: 10.1034/j.1600-0609.2002.01609.x. Eur J Haematol. 2002. PMID: 12038454

3

Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma.

Niitsu N, Hayama M, Okamoto M, Khori M, Higashihara M, Tamaru J, Hirano M. Niitsu N, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4077-82. doi: 10.1158/1078-0432.CCR-03-0658. Clin Cancer Res. 2004. PMID: 15217942 Clinical Trial.

4

Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma.

Niitsu N, Okamoto M, Aoki S, Okumura H, Yoshino T, Miura I, Hirano M. Niitsu N, et al. Ann Hematol. 2006 Jun;85(6):374-80. doi: 10.1007/s00277-006-0080-x. Epub 2006 Feb 22. Ann Hematol. 2006. PMID: 16518603 Clinical Trial.

5

Multicenter Phase II study of CyclOBEAP regimen for elderly patients with poor-prognosis aggressive lymphoma.

Niitsu N, Okamoto M, Kohori M, Aoki S, Miura I, Hirano M. Niitsu N, et al. Hematol Oncol. 2006 Dec;24(4):220-6. doi: 10.1002/hon.793. Hematol Oncol. 2006. PMID: 16958147 Clinical Trial.

6

Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.

Niitsu N, Okamoto M, Tomita N, Aoki S, Tamaru J, Miura I, Hirano M. Niitsu N, et al. Leuk Lymphoma. 2006 Sep;47(9):1908-14. doi: 10.1080/10428190600688313. Leuk Lymphoma. 2006. PMID: 17065005 Clinical Trial.

7

Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.

Niitsu N, Hayama M, Yoshino T, Nakamura S, Tamaru J, Nakamine H, Okamoto M. Niitsu N, et al. Br J Haematol. 2011 Jun;153(5):582-8. doi: 10.1111/j.1365-2141.2011.08634.x. Epub 2011 Apr 15. Br J Haematol. 2011. PMID: 21492124 Free article. Clinical Trial.

8

Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.

Niitsu N, Okabe-Kado J, Okamoto M, Takagi T, Yoshida T, Aoki S, Hirano M, Honma Y. Niitsu N, et al. Blood. 2001 Mar 1;97(5):1202-10. doi: 10.1182/blood.v97.5.1202. Blood. 2001. PMID: 11222361 Free article.

9

Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.

Niitsu N, Nakamine H, Okamoto M, Akamatsu H, Honma Y, Higashihara M, Okabe-Kado J, Hirano M; Adult Lymphoma Treatment Study Group, ALTSG. Niitsu N, et al. Br J Haematol. 2003 Nov;123(4):621-30. doi: 10.1046/j.1365-2141.2003.04668.x. Br J Haematol. 2003. PMID: 14616965 Free article.

10

Development of hepatosplenic gammadelta T-cell lymphoma with pancytopenia during early pregnancy: a case report and review of the literature.

Niitsu N, Kohri M, Togano T, Nakamine H, Nakamura S, Iwabuchi K, Higashihara M. Niitsu N, et al. Eur J Haematol. 2004 Nov;73(5):367-71. doi: 10.1111/j.1600-0609.2004.00300.x. Eur J Haematol. 2004. PMID: 15458516 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters